Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease
José Illnait, Iván Rodríguez, Sarahí Mendoza, Yolanda Fernández, Rosa Mas, Mirtha Miranda, Jesús Piñera, Julio César Fernández, Meilis Mesa, Lilia Fernández, Daisy Carbajal, Rafael Gámez
Korean J Intern Med. 2013;28(4):439-448. Published online 2013 Jul 1 DOI: https://doi.org/10.3904/kjim.2013.28.4.439
Citations to this article as recorded by 
BEE PRDUCTS AND THE POTENTIAL HEALTH ISSUES ARISING FROM THEIR UNCONTROLLED USE
Giyasettin Baydaş, Fatma Tutku Aksoy, Zeynep Güngördü Dalar, Merve Nur Aksakal, İpek Çoruhlu, Sara Çıbık, Elif Sena Ozcan, Öykü Toptaş, Zümra Kul
Türk Doğa ve Fen Dergisi.2024; 13(1): 176. CrossRef
Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds
Marcin Kosmalski, Rafał Frankowski, Kacper Deska, Monika Różycka-Kosmalska, Tadeusz Pietras
Nutrients.2023; 15(13): 2838. CrossRef
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis
Oluyemi Komolafe, Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas JG Chase, Dominic Fritche, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davids
Cochrane Database of Systematic Reviews.2021;[Epub] CrossRef
Beeswax: A minireview of its antimicrobial activity and its application in medicine
Filippo Fratini, Giovanni Cilia, Barbara Turchi, Antonio Felicioli
Asian Pacific Journal of Tropical Medicine.2016; 9(9): 839. CrossRef
Non‐alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies
M. Pallayova, S. Taheri
Clinical Obesity.2014; 4(5): 243. CrossRef
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
Kareem Hassan
World Journal of Gastroenterology.2014; 20(34): 12082. CrossRef